<?xml version="1.0" encoding="UTF-8"?>
<p id="Par47">The prevalence of SDRMs in recent infections was 2.4% in 2015, which was not significantly higher than that in 2014 (1.8%, χ
 <sup>2</sup> = 0.263, 
 <italic>p</italic> = 0.791) [
 <xref ref-type="bibr" rid="CR37">37</xref>]. However, we found that the prevalence of TDR increased with age. In the group that was above 50 years of age, the prevalence of TDR was over 5% and reached a moderate level, which should be considered. To control HIV-1 TDR, a priority is to strengthen the standard management of patients and regularly perform drug resistance surveillance.
</p>
